INO
Price
$1.86
Change
+$0.02 (+1.08%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
67.85M
RPTX
Price
$1.29
Change
-$0.08 (-5.84%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
58.24M
20 days until earnings call
Ad is loading...

INO vs RPTX

Header iconINO vs RPTX Comparison
Open Charts INO vs RPTXBanner chart's image
Inovio Pharmaceuticals
Price$1.86
Change+$0.02 (+1.08%)
Volume$4.83K
Capitalization67.85M
Repare Therapeutics
Price$1.29
Change-$0.08 (-5.84%)
Volume$8.62K
Capitalization58.24M
INO vs RPTX Comparison Chart
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. RPTX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a Buy and RPTX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (INO: $1.85 vs. RPTX: $1.37)
Brand notoriety: INO: Notable vs. RPTX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 70% vs. RPTX: 292%
Market capitalization -- INO: $67.85M vs. RPTX: $58.24M
INO [@Biotechnology] is valued at $67.85M. RPTX’s [@Biotechnology] market capitalization is $58.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 5 TA indicator(s) are bullish while RPTX’s TA Score has 4 bullish TA indicator(s).

  • INO’s TA Score: 5 bullish, 4 bearish.
  • RPTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INO is a better buy in the short-term than RPTX.

Price Growth

INO (@Biotechnology) experienced а +5.11% price change this week, while RPTX (@Biotechnology) price change was +24.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.67%. For the same industry, the average monthly price growth was -9.26%, and the average quarterly price growth was -12.98%.

Reported Earning Dates

INO is expected to report earnings on May 08, 2024.

RPTX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INO($67.8M) has a higher market cap than RPTX($58.2M). RPTX YTD gains are higher at: 4.580 vs. INO (3.933). RPTX has higher annual earnings (EBITDA): -90.22M vs. INO (-109.89M). RPTX has more cash in the bank: 153M vs. INO (84.8M). RPTX has less debt than INO: RPTX (1.93M) vs INO (12.4M). RPTX has higher revenues than INO: RPTX (53.5M) vs INO (203K).
INORPTXINO / RPTX
Capitalization67.8M58.2M116%
EBITDA-109.89M-90.22M122%
Gain YTD3.9334.58086%
P/E RatioN/AN/A-
Revenue203K53.5M0%
Total Cash84.8M153M55%
Total Debt12.4M1.93M641%
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INORPTX
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCRX7.820.29
+3.85%
BioCryst Pharmaceuticals
BKNG4598.08160.45
+3.62%
Booking Holdings
SIGI91.323.04
+3.44%
Selective Insurance Group
HRZN8.320.07
+0.85%
Horizon Technology Finance Corp
PMVP1.08-0.02
-1.82%
PMV Pharmaceuticals

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with RPTX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+3.93%
RPTX - INO
56%
Loosely correlated
+14.17%
AXON - INO
53%
Loosely correlated
+2.51%
ARRY - INO
52%
Loosely correlated
+2.63%
ONCO - INO
50%
Loosely correlated
+9.39%
BCYC - INO
49%
Loosely correlated
+16.24%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+14.17%
INO - RPTX
55%
Loosely correlated
+3.93%
BCYC - RPTX
48%
Loosely correlated
+16.24%
CADL - RPTX
39%
Loosely correlated
+4.99%
ALNY - RPTX
38%
Loosely correlated
+1.72%
AXON - RPTX
37%
Loosely correlated
+2.51%
More